Who founded Perseus SENOLYTIX?

Perseus SENOLYTIX was founded by Kevin Slawin, M.D..

Who are Perseus SENOLYTIX's investors?

Perseus SENOLYTIX's investors include Rapha Capital Management, LLC.

Where is Perseus SENOLYTIX headquartered?

Perseus SENOLYTIX is headquartered in Miami, US.

Perseus SENOLYTIX

Miami, US · 1 employees on LinkedIn · 1 known investors

Find your way into Perseus SENOLYTIX

Paths you didn't know you had: your email and LinkedIn already hold routes to the Perseus SENOLYTIX team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Perseus SENOLYTIX is a gerotherapeutics company developing senolytic peptides to target senescent cells and restore cellular balance in aging organisms. The company focuses on translating scientific discoveries into therapeutics addressing fundamental mechanisms of aging.

Biotech Deep Tech Longevity

Founders & leadership

Kevin Slawin, M.D.Founder and CEOKevin Slawin is a physician and biotech entrepreneur who co-founded Bellicum Pharmaceuticals, which completed an IPO in 2014, and has founded multiple companies in longevity and regenerative medicine including senolytic and gene therapy platforms. He has background as a robotic surgeon specializing in prostate cancer and co-invented diagnostic and immunotherapy technologies including the Prostate Health Index test and CAR-T cell approaches.

Michael A. Corsello, Ph.D.Vice President of Operations

Daniel Jasinski, Ph.D.Vice President of Research

Investors · 1

Rapha Capital Management, LLClisted by Rapha Capital Management, LLCSurfsidevia Kevin M. Slawin · inferred

How we know: Rapha Capital Management, LLC's portfolio page · Not right? Tell us

Frequently asked questions

What does Perseus SENOLYTIX do?: Perseus SENOLYTIX is a gerotherapeutics company developing senolytic peptides to target senescent cells and restore cellular balance in aging organisms. The company focuses on translating scientific discoveries into therapeutics addressing fundamental mechanisms of aging.
Who founded Perseus SENOLYTIX?: Perseus SENOLYTIX was founded by Kevin Slawin, M.D..
Who are Perseus SENOLYTIX's investors?: Perseus SENOLYTIX's investors include Rapha Capital Management, LLC.
Where is Perseus SENOLYTIX headquartered?: Perseus SENOLYTIX is headquartered in Miami, US.